Abingworth LLP
- SEC CIK
- 0001397144
No open-market purchases or sales filed in the past year.
Current role at each company
- JSPR Jasper Therapeutics, Inc.10% Owneras of Feb 12, 2024
- SLNO Soleno Therapeutics Inc10% Owneras of Oct 2, 2023
- VERA Vera Therapeutics, Inc.10% Owneras of Aug 19, 2022
- SRRA Sierra Oncology, Inc.10% Owneras of Feb 1, 2022
- EFTR eFFECTOR Therapeutics, Inc.10% Owneras of Dec 17, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Abingworth LLP as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
JSPR Jasper Therapeutics, Inc.
10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 12, 2024 (view filing)6:23 PM ET | Feb 8 | 4 days | TC Group, LLC and 9 others10% Owner | PPurchaseVoting Common Stock | +190.0K | $12.95 | +$2.46M | +21.7%1.07M after | |
| Jan 31, 2023 (view filing)5:24 PM ET | Jan 27 | 4 days | TC Group, LLC and 8 others10% Owner | PPurchaseVoting Common Stock | +3.13M | $1.50 | +$4.70M | +55.7%8.76M after |
SLNO Soleno Therapeutics Inc
10% Owner3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 10, 2023 (view filing)4:30 PM ET | May 8 | 2 days | TC Group, LLC and 8 others10% Owner | PPurchase | +2.87M | $0.4425 | +$1.27M | –1.78M after | Derivative2 lots |
| Mar 31, 2022 (view filing) | Mar 29 | 2 days | Abingworth LLP10% Owner | PPurchase | +7.72M | – | – | +74.9%18.0M after | Duplicate filing |
| Mar 31, 2022 (view filing) | Mar 29 | 2 days | Abingworth LLP10% Owner | PPurchase | +7.72M | – | – | –7.72M after | DerivativeDuplicate filing |
VERA Vera Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2022 (view filing)4:39 PM ET | Aug 17 | 2 days | TC Group, LLC and 9 others10% Owner | SSaleClass A Common Stock | −9.93K | $20.25 | −$201.0K | −0.3%2.96M after | 3 lots |
SRRA Sierra Oncology, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 1, 2022 (view filing) | Jan 31 | 1 day | Abingworth LLP10% Owner | PPurchaseCommon Stock, $0.001 par value | +150.0K | $27.00 | +$4.05M | +12.9%1.31M after |